nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—prostate cancer	0.116	0.313	CbGaD
Ticlopidine—CYP2E1—prostate cancer	0.0703	0.19	CbGaD
Ticlopidine—CYP2C19—prostate cancer	0.0696	0.189	CbGaD
Ticlopidine—CYP1A1—prostate cancer	0.0693	0.188	CbGaD
Ticlopidine—CYP3A4—prostate cancer	0.0443	0.12	CbGaD
Ticlopidine—CYP1A1—Flutamide—prostate cancer	0.0273	0.0652	CbGbCtD
Ticlopidine—CYP1A1—Estrone—prostate cancer	0.0197	0.0471	CbGbCtD
Ticlopidine—CYP2C8—Nilutamide—prostate cancer	0.019	0.0454	CbGbCtD
Ticlopidine—CYP2C19—Bicalutamide—prostate cancer	0.0159	0.0381	CbGbCtD
Ticlopidine—CYP2C19—Nilutamide—prostate cancer	0.0159	0.0381	CbGbCtD
Ticlopidine—CYP2C8—Abiraterone—prostate cancer	0.0157	0.0376	CbGbCtD
Ticlopidine—CYP2E1—Estrone—prostate cancer	0.0152	0.0364	CbGbCtD
Ticlopidine—CYP2B6—Estrone—prostate cancer	0.015	0.0359	CbGbCtD
Ticlopidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0147	0.0351	CbGbCtD
Ticlopidine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0134	0.032	CbGbCtD
Ticlopidine—CYP2C9—Nilutamide—prostate cancer	0.0132	0.0317	CbGbCtD
Ticlopidine—CYP2C9—Bicalutamide—prostate cancer	0.0132	0.0317	CbGbCtD
Ticlopidine—CYP2C19—Flutamide—prostate cancer	0.0132	0.0316	CbGbCtD
Ticlopidine—CYP1A2—Flutamide—prostate cancer	0.0122	0.0291	CbGbCtD
Ticlopidine—CYP2D6—Bicalutamide—prostate cancer	0.0121	0.029	CbGbCtD
Ticlopidine—CYP2C8—Cabazitaxel—prostate cancer	0.0116	0.0278	CbGbCtD
Ticlopidine—CYP1A1—Estradiol—prostate cancer	0.0113	0.0271	CbGbCtD
Ticlopidine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0101	0.0242	CbGbCtD
Ticlopidine—CYP2D6—Abiraterone—prostate cancer	0.01	0.024	CbGbCtD
Ticlopidine—CYP2E1—Mitoxantrone—prostate cancer	0.00905	0.0217	CbGbCtD
Ticlopidine—CYP1A2—Estrone—prostate cancer	0.0088	0.0211	CbGbCtD
Ticlopidine—CYP2C9—Estrone—prostate cancer	0.00793	0.019	CbGbCtD
Ticlopidine—CYP3A4—Bicalutamide—prostate cancer	0.0077	0.0184	CbGbCtD
Ticlopidine—CYP3A4—Estramustine—prostate cancer	0.00716	0.0171	CbGbCtD
Ticlopidine—CYP2C8—Estradiol—prostate cancer	0.00653	0.0156	CbGbCtD
Ticlopidine—CYP3A4—Flutamide—prostate cancer	0.00638	0.0153	CbGbCtD
Ticlopidine—CYP3A4—Abiraterone—prostate cancer	0.00638	0.0153	CbGbCtD
Ticlopidine—CYP2C9—Capecitabine—prostate cancer	0.00601	0.0144	CbGbCtD
Ticlopidine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00576	0.0138	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—prostate cancer	0.00571	0.0137	CbGbCtD
Ticlopidine—CYP2C19—Estradiol—prostate cancer	0.00548	0.0131	CbGbCtD
Ticlopidine—CYP1A2—Estradiol—prostate cancer	0.00506	0.0121	CbGbCtD
Ticlopidine—CYP3A4—Cabazitaxel—prostate cancer	0.00472	0.0113	CbGbCtD
Ticlopidine—CYP2C19—Prednisone—prostate cancer	0.00471	0.0113	CbGbCtD
Ticlopidine—CYP3A4—Estrone—prostate cancer	0.00461	0.011	CbGbCtD
Ticlopidine—CYP2C9—Estradiol—prostate cancer	0.00455	0.0109	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—prostate cancer	0.00426	0.0102	CbGbCtD
Ticlopidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00411	0.00983	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—prostate cancer	0.00384	0.00919	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—prostate cancer	0.0033	0.0079	CbGbCtD
Ticlopidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00302	0.00722	CbGbCtD
Ticlopidine—CYP3A4—Mitoxantrone—prostate cancer	0.00274	0.00656	CbGbCtD
Ticlopidine—CYP3A4—Estradiol—prostate cancer	0.00265	0.00634	CbGbCtD
Ticlopidine—P2RY12—prostate gland—prostate cancer	0.00231	0.111	CbGeAlD
Ticlopidine—CYP3A4—Prednisone—prostate cancer	0.00228	0.00545	CbGbCtD
Ticlopidine—CYP2C19—urine—prostate cancer	0.00189	0.0912	CbGeAlD
Ticlopidine—CYP2D6—Doxorubicin—prostate cancer	0.00185	0.00444	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—prostate cancer	0.00173	0.00414	CbGbCtD
Ticlopidine—P2RY12—epithelium—prostate cancer	0.0017	0.0819	CbGeAlD
Ticlopidine—CYP3A4—Docetaxel—prostate cancer	0.00158	0.00379	CbGbCtD
Ticlopidine—CYP1A2—urine—prostate cancer	0.00155	0.0745	CbGeAlD
Ticlopidine—CYP2C9—urine—prostate cancer	0.00147	0.0707	CbGeAlD
Ticlopidine—CYP2E1—urine—prostate cancer	0.00139	0.067	CbGeAlD
Ticlopidine—CYP3A4—Doxorubicin—prostate cancer	0.00118	0.00282	CbGbCtD
Ticlopidine—CYP3A4—urine—prostate cancer	0.00112	0.0539	CbGeAlD
Ticlopidine—CYP2D6—urine—prostate cancer	0.0011	0.0531	CbGeAlD
Ticlopidine—Clopidogrel—CYP3A5—prostate cancer	0.00101	0.473	CrCbGaD
Ticlopidine—MPO—epithelium—prostate cancer	0.000745	0.0359	CbGeAlD
Ticlopidine—MPO—renal system—prostate cancer	0.000691	0.0333	CbGeAlD
Ticlopidine—Clopidogrel—CYP2C19—prostate cancer	0.000688	0.322	CrCbGaD
Ticlopidine—MPO—bone marrow—prostate cancer	0.000523	0.0252	CbGeAlD
Ticlopidine—CYP2E1—prostate gland—prostate cancer	0.0005	0.0241	CbGeAlD
Ticlopidine—MPO—testis—prostate cancer	0.000447	0.0215	CbGeAlD
Ticlopidine—Clopidogrel—CYP3A4—prostate cancer	0.000437	0.205	CrCbGaD
Ticlopidine—CYP2E1—seminal vesicle—prostate cancer	0.000423	0.0204	CbGeAlD
Ticlopidine—CYP2C8—renal system—prostate cancer	0.000404	0.0195	CbGeAlD
Ticlopidine—CYP1A1—epithelium—prostate cancer	0.000403	0.0194	CbGeAlD
Ticlopidine—CYP1A2—renal system—prostate cancer	0.000378	0.0182	CbGeAlD
Ticlopidine—CYP1A1—renal system—prostate cancer	0.000373	0.018	CbGeAlD
Ticlopidine—CYP1A1—urethra—prostate cancer	0.000367	0.0177	CbGeAlD
Ticlopidine—CYP2B6—renal system—prostate cancer	0.000363	0.0175	CbGeAlD
Ticlopidine—CYP2E1—renal system—prostate cancer	0.00034	0.0164	CbGeAlD
Ticlopidine—CYP2E1—urethra—prostate cancer	0.000334	0.0161	CbGeAlD
Ticlopidine—MPO—lymph node—prostate cancer	0.000324	0.0156	CbGeAlD
Ticlopidine—CYP3A4—renal system—prostate cancer	0.000274	0.0132	CbGeAlD
Ticlopidine—CYP2D6—renal system—prostate cancer	0.00027	0.013	CbGeAlD
Ticlopidine—CYP2C8—testis—prostate cancer	0.000261	0.0126	CbGeAlD
Ticlopidine—CYP2B6—testis—prostate cancer	0.000235	0.0113	CbGeAlD
Ticlopidine—CYP2E1—testis—prostate cancer	0.00022	0.0106	CbGeAlD
Ticlopidine—CYP1A1—lymph node—prostate cancer	0.000175	0.00843	CbGeAlD
Ticlopidine—CYP2D6—testis—prostate cancer	0.000174	0.00839	CbGeAlD
Ticlopidine—Rash—Ethinyl Estradiol—prostate cancer	9.47e-05	0.00101	CcSEcCtD
Ticlopidine—Dermatitis—Ethinyl Estradiol—prostate cancer	9.46e-05	0.00101	CcSEcCtD
Ticlopidine—Renal failure—Capecitabine—prostate cancer	9.42e-05	0.001	CcSEcCtD
Ticlopidine—Headache—Ethinyl Estradiol—prostate cancer	9.41e-05	0.001	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Capecitabine—prostate cancer	9.39e-05	0.000998	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—prostate cancer	9.34e-05	0.000992	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—prostate cancer	9.22e-05	0.000979	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—prostate cancer	9.18e-05	0.000975	CcSEcCtD
Ticlopidine—Haematuria—Capecitabine—prostate cancer	9.14e-05	0.000971	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mitoxantrone—prostate cancer	9.13e-05	0.00097	CcSEcCtD
Ticlopidine—Hypersensitivity—Goserelin—prostate cancer	9.11e-05	0.000967	CcSEcCtD
Ticlopidine—Epistaxis—Capecitabine—prostate cancer	9.04e-05	0.00096	CcSEcCtD
Ticlopidine—Hypersensitivity—Conjugated Estrogens—prostate cancer	9.02e-05	0.000958	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—prostate cancer	8.99e-05	0.000955	CcSEcCtD
Ticlopidine—Vascular purpura—Doxorubicin—prostate cancer	8.96e-05	0.000952	CcSEcCtD
Ticlopidine—Muscle spasms—Etoposide—prostate cancer	8.95e-05	0.00095	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mitoxantrone—prostate cancer	8.94e-05	0.00095	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—prostate cancer	8.93e-05	0.000949	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Estradiol—prostate cancer	8.93e-05	0.000948	CcSEcCtD
Ticlopidine—Nausea—Ethinyl Estradiol—prostate cancer	8.92e-05	0.000948	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—prostate cancer	8.92e-05	0.000947	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—prostate cancer	8.89e-05	0.000944	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—prostate cancer	8.89e-05	0.000944	CcSEcCtD
Ticlopidine—Asthenia—Goserelin—prostate cancer	8.87e-05	0.000942	CcSEcCtD
Ticlopidine—Asthenia—Conjugated Estrogens—prostate cancer	8.79e-05	0.000933	CcSEcCtD
Ticlopidine—Pruritus—Goserelin—prostate cancer	8.75e-05	0.000929	CcSEcCtD
Ticlopidine—Anorexia—Mitoxantrone—prostate cancer	8.71e-05	0.000925	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—prostate cancer	8.7e-05	0.000924	CcSEcCtD
Ticlopidine—Pruritus—Conjugated Estrogens—prostate cancer	8.66e-05	0.00092	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—prostate cancer	8.66e-05	0.00092	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	8.66e-05	0.00092	CcSEcCtD
Ticlopidine—Haemoglobin—Capecitabine—prostate cancer	8.65e-05	0.000918	CcSEcCtD
Ticlopidine—Dyspepsia—Estradiol—prostate cancer	8.63e-05	0.000916	CcSEcCtD
Ticlopidine—Hepatitis—Capecitabine—prostate cancer	8.6e-05	0.000914	CcSEcCtD
Ticlopidine—Haemorrhage—Capecitabine—prostate cancer	8.6e-05	0.000914	CcSEcCtD
Ticlopidine—Decreased appetite—Estradiol—prostate cancer	8.52e-05	0.000905	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—prostate cancer	8.5e-05	0.000902	CcSEcCtD
Ticlopidine—Diarrhoea—Goserelin—prostate cancer	8.46e-05	0.000898	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—prostate cancer	8.4e-05	0.000892	CcSEcCtD
Ticlopidine—Pain—Estradiol—prostate cancer	8.38e-05	0.00089	CcSEcCtD
Ticlopidine—Diarrhoea—Conjugated Estrogens—prostate cancer	8.38e-05	0.00089	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Prednisone—prostate cancer	8.37e-05	0.000889	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	8.32e-05	0.000884	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—prostate cancer	8.32e-05	0.000883	CcSEcCtD
Ticlopidine—Dizziness—Goserelin—prostate cancer	8.18e-05	0.000868	CcSEcCtD
Ticlopidine—Erythema multiforme—Capecitabine—prostate cancer	8.13e-05	0.000864	CcSEcCtD
Ticlopidine—Dizziness—Conjugated Estrogens—prostate cancer	8.1e-05	0.00086	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—prostate cancer	8.05e-05	0.000855	CcSEcCtD
Ticlopidine—Dyspepsia—Mitoxantrone—prostate cancer	8.04e-05	0.000854	CcSEcCtD
Ticlopidine—Tinnitus—Capecitabine—prostate cancer	8.02e-05	0.000852	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—prostate cancer	8.02e-05	0.000851	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	8.02e-05	0.000851	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Estradiol—prostate cancer	8.01e-05	0.000851	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—prostate cancer	8e-05	0.00085	CcSEcCtD
Ticlopidine—Decreased appetite—Mitoxantrone—prostate cancer	7.94e-05	0.000843	CcSEcCtD
Ticlopidine—Vomiting—Goserelin—prostate cancer	7.86e-05	0.000835	CcSEcCtD
Ticlopidine—Pain—Mitoxantrone—prostate cancer	7.81e-05	0.000829	CcSEcCtD
Ticlopidine—Rash—Goserelin—prostate cancer	7.8e-05	0.000828	CcSEcCtD
Ticlopidine—Dermatitis—Goserelin—prostate cancer	7.79e-05	0.000827	CcSEcCtD
Ticlopidine—Vomiting—Conjugated Estrogens—prostate cancer	7.79e-05	0.000827	CcSEcCtD
Ticlopidine—Urticaria—Estradiol—prostate cancer	7.79e-05	0.000827	CcSEcCtD
Ticlopidine—Body temperature increased—Estradiol—prostate cancer	7.75e-05	0.000823	CcSEcCtD
Ticlopidine—Headache—Goserelin—prostate cancer	7.75e-05	0.000823	CcSEcCtD
Ticlopidine—Rash—Conjugated Estrogens—prostate cancer	7.72e-05	0.00082	CcSEcCtD
Ticlopidine—Dermatitis—Conjugated Estrogens—prostate cancer	7.71e-05	0.000819	CcSEcCtD
Ticlopidine—Haemoglobin—Prednisone—prostate cancer	7.7e-05	0.000818	CcSEcCtD
Ticlopidine—Headache—Conjugated Estrogens—prostate cancer	7.67e-05	0.000815	CcSEcCtD
Ticlopidine—Haemorrhage—Prednisone—prostate cancer	7.66e-05	0.000814	CcSEcCtD
Ticlopidine—Anaphylactic shock—Etoposide—prostate cancer	7.6e-05	0.000807	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—prostate cancer	7.54e-05	0.000801	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mitoxantrone—prostate cancer	7.47e-05	0.000793	CcSEcCtD
Ticlopidine—Thrombocytopenia—Etoposide—prostate cancer	7.44e-05	0.00079	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—prostate cancer	7.44e-05	0.00079	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—prostate cancer	7.41e-05	0.000787	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—prostate cancer	7.4e-05	0.000786	CcSEcCtD
Ticlopidine—Flatulence—Capecitabine—prostate cancer	7.38e-05	0.000784	CcSEcCtD
Ticlopidine—Nausea—Goserelin—prostate cancer	7.34e-05	0.00078	CcSEcCtD
Ticlopidine—Nausea—Conjugated Estrogens—prostate cancer	7.27e-05	0.000773	CcSEcCtD
Ticlopidine—Urticaria—Mitoxantrone—prostate cancer	7.26e-05	0.000771	CcSEcCtD
Ticlopidine—Anorexia—Etoposide—prostate cancer	7.24e-05	0.000769	CcSEcCtD
Ticlopidine—Hypersensitivity—Estradiol—prostate cancer	7.22e-05	0.000767	CcSEcCtD
Ticlopidine—Body temperature increased—Mitoxantrone—prostate cancer	7.22e-05	0.000767	CcSEcCtD
Ticlopidine—Muscle spasms—Capecitabine—prostate cancer	7.2e-05	0.000765	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—prostate cancer	7.11e-05	0.000755	CcSEcCtD
Ticlopidine—Asthenia—Estradiol—prostate cancer	7.03e-05	0.000747	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—prostate cancer	6.98e-05	0.000741	CcSEcCtD
Ticlopidine—Pruritus—Estradiol—prostate cancer	6.93e-05	0.000737	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—prostate cancer	6.86e-05	0.000729	CcSEcCtD
Ticlopidine—Hypersensitivity—Mitoxantrone—prostate cancer	6.73e-05	0.000715	CcSEcCtD
Ticlopidine—Diarrhoea—Estradiol—prostate cancer	6.71e-05	0.000712	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	6.62e-05	0.000703	CcSEcCtD
Ticlopidine—Decreased appetite—Etoposide—prostate cancer	6.6e-05	0.000701	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—prostate cancer	6.59e-05	0.000699	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—prostate cancer	6.59e-05	0.000699	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—prostate cancer	6.58e-05	0.000699	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—prostate cancer	6.56e-05	0.000697	CcSEcCtD
Ticlopidine—Asthenia—Mitoxantrone—prostate cancer	6.55e-05	0.000696	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—prostate cancer	6.54e-05	0.000695	CcSEcCtD
Ticlopidine—Pain—Etoposide—prostate cancer	6.5e-05	0.00069	CcSEcCtD
Ticlopidine—Dizziness—Estradiol—prostate cancer	6.48e-05	0.000688	CcSEcCtD
Ticlopidine—Arthralgia—Capecitabine—prostate cancer	6.38e-05	0.000677	CcSEcCtD
Ticlopidine—Myalgia—Capecitabine—prostate cancer	6.38e-05	0.000677	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—prostate cancer	6.37e-05	0.000676	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—prostate cancer	6.31e-05	0.000671	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—prostate cancer	6.3e-05	0.000669	CcSEcCtD
Ticlopidine—Diarrhoea—Mitoxantrone—prostate cancer	6.25e-05	0.000664	CcSEcCtD
Ticlopidine—Vomiting—Estradiol—prostate cancer	6.23e-05	0.000662	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—prostate cancer	6.21e-05	0.00066	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—prostate cancer	6.18e-05	0.000657	CcSEcCtD
Ticlopidine—Rash—Estradiol—prostate cancer	6.18e-05	0.000656	CcSEcCtD
Ticlopidine—Dermatitis—Estradiol—prostate cancer	6.17e-05	0.000656	CcSEcCtD
Ticlopidine—Headache—Estradiol—prostate cancer	6.14e-05	0.000652	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	6.12e-05	0.000651	CcSEcCtD
Ticlopidine—Angioedema—Prednisone—prostate cancer	6.1e-05	0.000647	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—prostate cancer	6.07e-05	0.000645	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—prostate cancer	6.06e-05	0.000643	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—prostate cancer	6.03e-05	0.000641	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—prostate cancer	6.02e-05	0.00064	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—prostate cancer	6.02e-05	0.000639	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—prostate cancer	6.01e-05	0.000638	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—prostate cancer	5.99e-05	0.000637	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—prostate cancer	5.99e-05	0.000637	CcSEcCtD
Ticlopidine—Thrombocytopenia—Capecitabine—prostate cancer	5.98e-05	0.000636	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—prostate cancer	5.89e-05	0.000626	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—prostate cancer	5.83e-05	0.000619	CcSEcCtD
Ticlopidine—Anorexia—Capecitabine—prostate cancer	5.83e-05	0.000619	CcSEcCtD
Ticlopidine—Nausea—Estradiol—prostate cancer	5.82e-05	0.000618	CcSEcCtD
Ticlopidine—Vomiting—Mitoxantrone—prostate cancer	5.81e-05	0.000617	CcSEcCtD
Ticlopidine—Rash—Mitoxantrone—prostate cancer	5.76e-05	0.000612	CcSEcCtD
Ticlopidine—Dermatitis—Mitoxantrone—prostate cancer	5.75e-05	0.000611	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.75e-05	0.000611	CcSEcCtD
Ticlopidine—Headache—Mitoxantrone—prostate cancer	5.72e-05	0.000608	CcSEcCtD
Ticlopidine—Myalgia—Prednisone—prostate cancer	5.68e-05	0.000603	CcSEcCtD
Ticlopidine—Arthralgia—Prednisone—prostate cancer	5.68e-05	0.000603	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—prostate cancer	5.67e-05	0.000602	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—prostate cancer	5.6e-05	0.000594	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—prostate cancer	5.59e-05	0.000594	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—prostate cancer	5.57e-05	0.000592	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.57e-05	0.000591	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—prostate cancer	5.56e-05	0.00059	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—prostate cancer	5.55e-05	0.000589	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—prostate cancer	5.55e-05	0.000589	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—prostate cancer	5.49e-05	0.000583	CcSEcCtD
Ticlopidine—Asthenia—Etoposide—prostate cancer	5.45e-05	0.000579	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisone—prostate cancer	5.44e-05	0.000578	CcSEcCtD
Ticlopidine—Nausea—Mitoxantrone—prostate cancer	5.42e-05	0.000576	CcSEcCtD
Ticlopidine—Pain—Docetaxel—prostate cancer	5.4e-05	0.000573	CcSEcCtD
Ticlopidine—Dyspepsia—Capecitabine—prostate cancer	5.38e-05	0.000571	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—prostate cancer	5.37e-05	0.000571	CcSEcCtD
Ticlopidine—Decreased appetite—Capecitabine—prostate cancer	5.31e-05	0.000564	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—prostate cancer	5.24e-05	0.000557	CcSEcCtD
Ticlopidine—Pain—Capecitabine—prostate cancer	5.23e-05	0.000555	CcSEcCtD
Ticlopidine—Diarrhoea—Etoposide—prostate cancer	5.2e-05	0.000552	CcSEcCtD
Ticlopidine—Anorexia—Prednisone—prostate cancer	5.19e-05	0.000551	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—prostate cancer	5.17e-05	0.000549	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—prostate cancer	5.16e-05	0.000548	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—prostate cancer	5.14e-05	0.000546	CcSEcCtD
Ticlopidine—Dizziness—Etoposide—prostate cancer	5.02e-05	0.000534	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—prostate cancer	5.02e-05	0.000533	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Capecitabine—prostate cancer	5e-05	0.000531	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—prostate cancer	4.99e-05	0.00053	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Prednisone—prostate cancer	4.96e-05	0.000527	CcSEcCtD
Ticlopidine—Urticaria—Capecitabine—prostate cancer	4.86e-05	0.000516	CcSEcCtD
Ticlopidine—Body temperature increased—Capecitabine—prostate cancer	4.83e-05	0.000513	CcSEcCtD
Ticlopidine—Vomiting—Etoposide—prostate cancer	4.83e-05	0.000513	CcSEcCtD
Ticlopidine—Dyspepsia—Prednisone—prostate cancer	4.79e-05	0.000509	CcSEcCtD
Ticlopidine—Rash—Etoposide—prostate cancer	4.79e-05	0.000509	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—prostate cancer	4.79e-05	0.000508	CcSEcCtD
Ticlopidine—Headache—Etoposide—prostate cancer	4.76e-05	0.000505	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—prostate cancer	4.76e-05	0.000505	CcSEcCtD
Ticlopidine—Decreased appetite—Prednisone—prostate cancer	4.73e-05	0.000503	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—prostate cancer	4.65e-05	0.000494	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—prostate cancer	4.64e-05	0.000493	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—prostate cancer	4.53e-05	0.000481	CcSEcCtD
Ticlopidine—Nausea—Etoposide—prostate cancer	4.51e-05	0.000479	CcSEcCtD
Ticlopidine—Hypersensitivity—Capecitabine—prostate cancer	4.5e-05	0.000478	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—prostate cancer	4.47e-05	0.000474	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Prednisone—prostate cancer	4.45e-05	0.000473	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—prostate cancer	4.44e-05	0.000472	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—prostate cancer	4.44e-05	0.000472	CcSEcCtD
Ticlopidine—Asthenia—Capecitabine—prostate cancer	4.39e-05	0.000466	CcSEcCtD
Ticlopidine—Urticaria—Prednisone—prostate cancer	4.33e-05	0.000459	CcSEcCtD
Ticlopidine—Pruritus—Capecitabine—prostate cancer	4.32e-05	0.000459	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—prostate cancer	4.32e-05	0.000459	CcSEcCtD
Ticlopidine—Body temperature increased—Prednisone—prostate cancer	4.3e-05	0.000457	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—prostate cancer	4.26e-05	0.000452	CcSEcCtD
Ticlopidine—Diarrhoea—Capecitabine—prostate cancer	4.18e-05	0.000444	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—prostate cancer	4.17e-05	0.000443	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—prostate cancer	4.17e-05	0.000443	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—prostate cancer	4.11e-05	0.000437	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—prostate cancer	4.11e-05	0.000437	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—prostate cancer	4.06e-05	0.000431	CcSEcCtD
Ticlopidine—Dizziness—Capecitabine—prostate cancer	4.04e-05	0.000429	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—prostate cancer	4.01e-05	0.000426	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisone—prostate cancer	4.01e-05	0.000426	CcSEcCtD
Ticlopidine—Rash—Docetaxel—prostate cancer	3.98e-05	0.000423	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—prostate cancer	3.98e-05	0.000422	CcSEcCtD
Ticlopidine—Headache—Docetaxel—prostate cancer	3.95e-05	0.00042	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—prostate cancer	3.94e-05	0.000418	CcSEcCtD
Ticlopidine—Asthenia—Prednisone—prostate cancer	3.91e-05	0.000415	CcSEcCtD
Ticlopidine—Vomiting—Capecitabine—prostate cancer	3.89e-05	0.000413	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.88e-05	0.000412	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—prostate cancer	3.86e-05	0.00041	CcSEcCtD
Ticlopidine—Rash—Capecitabine—prostate cancer	3.85e-05	0.000409	CcSEcCtD
Ticlopidine—Pruritus—Prednisone—prostate cancer	3.85e-05	0.000409	CcSEcCtD
Ticlopidine—Dermatitis—Capecitabine—prostate cancer	3.85e-05	0.000409	CcSEcCtD
Ticlopidine—Headache—Capecitabine—prostate cancer	3.83e-05	0.000407	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—prostate cancer	3.76e-05	0.000399	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—prostate cancer	3.75e-05	0.000398	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—prostate cancer	3.75e-05	0.000398	CcSEcCtD
Ticlopidine—Diarrhoea—Prednisone—prostate cancer	3.73e-05	0.000396	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—prostate cancer	3.7e-05	0.000393	CcSEcCtD
Ticlopidine—Pain—Epirubicin—prostate cancer	3.64e-05	0.000387	CcSEcCtD
Ticlopidine—Nausea—Capecitabine—prostate cancer	3.63e-05	0.000386	CcSEcCtD
Ticlopidine—Dizziness—Prednisone—prostate cancer	3.6e-05	0.000382	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.59e-05	0.000381	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—prostate cancer	3.48e-05	0.00037	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—prostate cancer	3.47e-05	0.000368	CcSEcCtD
Ticlopidine—Vomiting—Prednisone—prostate cancer	3.46e-05	0.000368	CcSEcCtD
Ticlopidine—Rash—Prednisone—prostate cancer	3.43e-05	0.000365	CcSEcCtD
Ticlopidine—Dermatitis—Prednisone—prostate cancer	3.43e-05	0.000364	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—prostate cancer	3.43e-05	0.000364	CcSEcCtD
Ticlopidine—Headache—Prednisone—prostate cancer	3.41e-05	0.000362	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—prostate cancer	3.38e-05	0.000359	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—prostate cancer	3.37e-05	0.000358	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—prostate cancer	3.37e-05	0.000358	CcSEcCtD
Ticlopidine—Nausea—Prednisone—prostate cancer	3.23e-05	0.000343	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.22e-05	0.000342	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—prostate cancer	3.14e-05	0.000333	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—prostate cancer	3.13e-05	0.000332	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—prostate cancer	3.11e-05	0.000331	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—prostate cancer	3.06e-05	0.000324	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—prostate cancer	3.01e-05	0.00032	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—prostate cancer	2.91e-05	0.000309	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—prostate cancer	2.9e-05	0.000308	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—prostate cancer	2.83e-05	0.0003	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—prostate cancer	2.82e-05	0.000299	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—prostate cancer	2.79e-05	0.000296	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—prostate cancer	2.71e-05	0.000288	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—prostate cancer	2.7e-05	0.000286	CcSEcCtD
Ticlopidine—Rash—Epirubicin—prostate cancer	2.68e-05	0.000285	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—prostate cancer	2.68e-05	0.000285	CcSEcCtD
Ticlopidine—Headache—Epirubicin—prostate cancer	2.67e-05	0.000283	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—prostate cancer	2.61e-05	0.000277	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—prostate cancer	2.53e-05	0.000269	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—prostate cancer	2.51e-05	0.000266	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—prostate cancer	2.48e-05	0.000264	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—prostate cancer	2.48e-05	0.000264	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—prostate cancer	2.47e-05	0.000262	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—prostate cancer	2.34e-05	0.000249	CcSEcCtD
Ticlopidine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.01e-06	2.1e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NQO1—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TH—prostate cancer	2e-06	2.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.99e-06	2.08e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKR1C3—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TH—prostate cancer	1.98e-06	2.06e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.98e-06	2.06e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PRKACB—prostate cancer	1.98e-06	2.06e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—prostate cancer	1.97e-06	2.06e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PLCB2—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—LRP2—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.96e-06	2.04e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.95e-06	2.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—prostate cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.94e-06	2.02e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ERCC2—prostate cancer	1.94e-06	2.02e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARA—prostate cancer	1.94e-06	2.02e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—prostate cancer	1.93e-06	2.02e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—P4HB—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—RXRA—prostate cancer	1.92e-06	2e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—prostate cancer	1.91e-06	1.99e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARA—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—prostate cancer	1.89e-06	1.97e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GGT1—prostate cancer	1.88e-06	1.96e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.88e-06	1.96e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GGT1—prostate cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOA2—prostate cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—LPL—prostate cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.85e-06	1.93e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—COMT—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTP1—prostate cancer	1.84e-06	1.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NCOA1—prostate cancer	1.84e-06	1.91e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.83e-06	1.91e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—prostate cancer	1.82e-06	1.9e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CAV1—prostate cancer	1.82e-06	1.9e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.81e-06	1.89e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.81e-06	1.88e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MED12—prostate cancer	1.8e-06	1.88e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—prostate cancer	1.8e-06	1.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.79e-06	1.87e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARA—prostate cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GNG5—prostate cancer	1.79e-06	1.86e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CAV1—prostate cancer	1.78e-06	1.86e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ERCC2—prostate cancer	1.78e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.78e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.78e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—RXRA—prostate cancer	1.76e-06	1.84e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—RXRA—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.72e-06	1.8e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NQO1—prostate cancer	1.72e-06	1.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—prostate cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—COMT—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TH—prostate cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—COMT—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CAV1—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.66e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.66e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—LPL—prostate cancer	1.66e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.65e-06	1.72e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.65e-06	1.72e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.64e-06	1.71e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARA—prostate cancer	1.64e-06	1.71e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.63e-06	1.7e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.62e-06	1.69e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.62e-06	1.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.6e-06	1.67e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.59e-06	1.66e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ACHE—prostate cancer	1.59e-06	1.66e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GGT1—prostate cancer	1.59e-06	1.66e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.59e-06	1.65e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.58e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—prostate cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—INS—prostate cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—prostate cancer	1.56e-06	1.62e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.55e-06	1.62e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.55e-06	1.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CAV1—prostate cancer	1.54e-06	1.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CREBBP—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—INS—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.53e-06	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.53e-06	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—LPL—prostate cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—LPL—prostate cancer	1.51e-06	1.57e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.51e-06	1.57e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CREBBP—prostate cancer	1.51e-06	1.57e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—RXRA—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.49e-06	1.56e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.47e-06	1.54e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.53e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARA—prostate cancer	1.46e-06	1.53e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—INS—prostate cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.45e-06	1.51e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—COMT—prostate cancer	1.44e-06	1.5e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.44e-06	1.5e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CREBBP—prostate cancer	1.42e-06	1.48e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NOS3—prostate cancer	1.38e-06	1.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CAV1—prostate cancer	1.38e-06	1.43e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.36e-06	1.42e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NOS3—prostate cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARA—prostate cancer	1.35e-06	1.4e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARA—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—INS—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NQO1—prostate cancer	1.32e-06	1.38e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.31e-06	1.37e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TH—prostate cancer	1.31e-06	1.36e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.3e-06	1.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—LPL—prostate cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NOS3—prostate cancer	1.27e-06	1.33e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CAV1—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CAV1—prostate cancer	1.25e-06	1.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.25e-06	1.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.25e-06	1.3e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.23e-06	1.29e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—prostate cancer	1.23e-06	1.29e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GGT1—prostate cancer	1.23e-06	1.28e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.2e-06	1.25e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—INS—prostate cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NOS3—prostate cancer	1.17e-06	1.22e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—prostate cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—RXRA—prostate cancer	1.15e-06	1.2e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARA—prostate cancer	1.14e-06	1.19e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—COMT—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.1e-06	1.15e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.1e-06	1.15e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—INS—prostate cancer	1.09e-06	1.14e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—INS—prostate cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—prostate cancer	1.08e-06	1.12e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CAV1—prostate cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.07e-06	1.11e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NOS3—prostate cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.02e-06	1.07e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—prostate cancer	1.01e-06	1.06e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1e-06	1.05e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—LPL—prostate cancer	9.97e-07	1.04e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—prostate cancer	9.77e-07	1.02e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—prostate cancer	9.67e-07	1.01e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.62e-07	1e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.61e-07	1e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NOS3—prostate cancer	9.57e-07	9.98e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ERCC2—prostate cancer	9.55e-07	9.95e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—prostate cancer	9.52e-07	9.92e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NOS3—prostate cancer	9.49e-07	9.89e-06	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—prostate cancer	9.3e-07	9.69e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—INS—prostate cancer	9.25e-07	9.64e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CREBBP—prostate cancer	9.06e-07	9.44e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—prostate cancer	8.97e-07	9.35e-06	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—prostate cancer	8.87e-07	9.24e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.84e-07	9.21e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARA—prostate cancer	8.8e-07	9.17e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.76e-07	9.13e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—prostate cancer	8.75e-07	9.12e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—prostate cancer	8.68e-07	9.05e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.59e-07	8.95e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—prostate cancer	8.3e-07	8.65e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CAV1—prostate cancer	8.28e-07	8.63e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NOS3—prostate cancer	8.11e-07	8.45e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—prostate cancer	7.92e-07	8.25e-06	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—prostate cancer	7.75e-07	8.08e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—prostate cancer	7.63e-07	7.96e-06	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—prostate cancer	7.59e-07	7.91e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—prostate cancer	7.57e-07	7.89e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.54e-07	7.86e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.48e-07	7.8e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—prostate cancer	7.42e-07	7.73e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—prostate cancer	7.28e-07	7.59e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—prostate cancer	7.22e-07	7.52e-06	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—prostate cancer	7.16e-07	7.46e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—INS—prostate cancer	7.14e-07	7.44e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CREBBP—prostate cancer	6.99e-07	7.28e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.63e-07	6.91e-06	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—prostate cancer	6.56e-07	6.84e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—prostate cancer	6.47e-07	6.74e-06	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—prostate cancer	6.33e-07	6.6e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NOS3—prostate cancer	6.26e-07	6.52e-06	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—prostate cancer	6.2e-07	6.46e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—prostate cancer	6.17e-07	6.43e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.86e-07	6.1e-06	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—prostate cancer	5.85e-07	6.09e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.78e-07	6.02e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—prostate cancer	5.72e-07	5.97e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.39e-07	5.61e-06	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—prostate cancer	5.36e-07	5.59e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.34e-07	5.56e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—prostate cancer	4.99e-07	5.2e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—prostate cancer	4.78e-07	4.99e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—prostate cancer	4.76e-07	4.96e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.56e-07	4.76e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—prostate cancer	4.4e-07	4.59e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—prostate cancer	4.36e-07	4.55e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—prostate cancer	3.73e-07	3.88e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.52e-07	3.67e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—prostate cancer	2.88e-07	3e-06	CbGpPWpGaD
